| scholarly article | Q13442814 |
| P50 | author | Jae Hyung Kim | Q64482272 |
| Young Jun Oh | Q79250623 | ||
| Gautam Sikka | Q117789925 | ||
| P2093 | author name string | David W Christianson | |
| Lakshmi Santhanam | |||
| Kevin G Soucy | |||
| Sungwoo Ryoo | |||
| Hunter C Champion | |||
| Trinity J Bivalacqua | |||
| Dan E Berkowitz | |||
| Daniel Nyhan | |||
| Jae Hyung Kim | |||
| Artin A Shoukas | |||
| Andre Camara | |||
| Monica Ilies | |||
| Lukasz J Bugaj | |||
| Alanah Webb | |||
| P2860 | cites work | Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2 | Q24299661 |
| Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. | Q24532108 | ||
| Oxidants, oxidative stress and the biology of ageing | Q28131725 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction | Q28567225 | ||
| Development of progressive aortic vasculopathy in a rat model of aging | Q28583371 | ||
| Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress | Q29615436 | ||
| Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension | Q30080036 | ||
| Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load | Q33743649 | ||
| Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases | Q34113189 | ||
| Oxygen reduction by nitric-oxide synthases | Q34201782 | ||
| Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study | Q34494252 | ||
| Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis | Q35095605 | ||
| Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness | Q35216439 | ||
| Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? | Q35582181 | ||
| Structure and function of arginases | Q35909707 | ||
| Arginase: a critical regulator of nitric oxide synthesis and vascular function | Q35954810 | ||
| Vascular inflammation in aging | Q35984535 | ||
| Endothelial aging | Q36093530 | ||
| Enhanced peroxynitrite formation is associated with vascular aging | Q36404553 | ||
| Endothelial arginase: a new target in atherosclerosis | Q36442590 | ||
| Ageing of the conduit arteries | Q36698238 | ||
| Vascular smooth muscle and endothelial functions in aging | Q36802152 | ||
| Inflammation and endothelial dysfunction during aging: role of NF-kappaB | Q36956379 | ||
| Arginase and vascular aging | Q36977086 | ||
| Selective fluorescent labeling of S-nitrosothiols (S-FLOS): a novel method for studying S-nitrosation. | Q36995195 | ||
| Reactive oxygen species as mediators of signal transduction in cardiovascular disease | Q37828680 | ||
| Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2. | Q40047128 | ||
| Improved arterial compliance by a novel advanced glycation end-product crosslink breaker | Q40684856 | ||
| Diabetes-induced coronary vascular dysfunction involves increased arginase activity | Q41817278 | ||
| Alterations of nitric oxide synthase expression with aging and hypertension in rats | Q42450617 | ||
| Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction | Q43605519 | ||
| Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study | Q43859232 | ||
| Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function | Q44028489 | ||
| NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats | Q44547281 | ||
| Arginase and autoimmune inflammation in the central nervous system | Q44563491 | ||
| Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels | Q44601105 | ||
| Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. | Q44772508 | ||
| Involvement of increased arginase activity in impaired cavernous relaxation with aging in the rabbit | Q44940159 | ||
| Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin | Q45023381 | ||
| Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles | Q45113050 | ||
| Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension | Q45182794 | ||
| Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase | Q45863383 | ||
| Endothelial arginase II: a novel target for the treatment of atherosclerosis | Q46726767 | ||
| Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles | Q46862881 | ||
| Knockdown of arginase I restores NO signaling in the vasculature of old rats. | Q46870256 | ||
| Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases | Q46979575 | ||
| Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. | Q50336020 | ||
| Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness. | Q51104632 | ||
| Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. | Q52573945 | ||
| Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. | Q53850917 | ||
| Arterial Stiffness and Risk of Coronary Heart Disease and Stroke | Q57781936 | ||
| Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction | Q72286695 | ||
| Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats | Q77114829 | ||
| Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age | Q77350579 | ||
| Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium | Q77894868 | ||
| Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A | Q80161975 | ||
| Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age | Q80281483 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1249-1257 | |
| P577 | publication date | 2009-08-06 | |
| P1433 | published in | Journal of Applied Physiology | Q1091719 |
| P1476 | title | Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats | |
| P478 | volume | 107 |
| Q41037479 | A relative L-arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition |
| Q43525134 | Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans |
| Q34973749 | Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function |
| Q35177586 | Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness |
| Q37856761 | Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors |
| Q35217395 | Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function |
| Q36110484 | Arginase II inhibition prevents nitrate tolerance. |
| Q41151610 | Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice |
| Q26991946 | Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis |
| Q41285088 | Arginase as a mediator of diabetic retinopathy |
| Q38082329 | Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? |
| Q92497394 | Arginase impairs hypoxic pulmonary vasoconstriction in murine endotoxemia |
| Q34800913 | Arginase in retinopathy |
| Q35181215 | Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia. |
| Q41572196 | Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs |
| Q36854784 | Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats |
| Q37500202 | Arginase-1 deficiency regulates arginine concentrations and NOS2-mediated NO production during endotoxemia. |
| Q36268285 | Arginase-I enhances vascular endothelial inflammation and senescence through eNOS-uncoupling |
| Q50143099 | Arginase: A Multifaceted Enzyme Important in Health and Disease. |
| Q38452432 | Arginase: an old enzyme with new tricks |
| Q36920831 | Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation |
| Q38362838 | Arginine and citrulline and the immune response in sepsis. |
| Q38112398 | Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects |
| Q35043143 | Arterial Stiffness |
| Q34008329 | Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease |
| Q37728774 | Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus |
| Q37235264 | Blockade of Urotensin II Receptor Prevents Vascular Dysfunction |
| Q33999976 | Bothrops jararaca peptide with anti-hypertensive action normalizes endothelium dysfunction involved in physiopathology of preeclampsia |
| Q37442678 | Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target? |
| Q60609999 | Cardiovascular Adaptations to Anemia and the Vascular Endothelium in Sickle Cell Disease Pathophysiology |
| Q48170250 | Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice |
| Q43077015 | Changes in aortic stiffness related to elastic fiber network anomalies in the Brown Norway rat during maturation and aging |
| Q33642371 | Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats |
| Q36682074 | Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma |
| Q36570080 | Curcumin ameliorates arterial dysfunction and oxidative stress with aging |
| Q38598866 | Diabetes and ageing-induced vascular inflammation |
| Q36056243 | Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. |
| Q47845782 | EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress. |
| Q41457723 | Effect of Pneumoperitoneum on Oxidative Stress and Inflammation via the Arginase Pathway in Rats |
| Q35215102 | Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus |
| Q35111227 | Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia |
| Q33914406 | Effects of aging on angiogenesis |
| Q34958259 | Efficacy of female rat models in translational cardiovascular aging research |
| Q34501755 | Enteral arginase II provides ornithine for citrulline synthesis |
| Q33761211 | European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). |
| Q34406933 | Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders |
| Q64376094 | Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways |
| Q39271619 | Immunobiology of Nitric Oxide and Regulation of Inducible Nitric Oxide Synthase |
| Q46358618 | Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries |
| Q34576393 | In vivo assessment of arterial stiffness in the isoflurane anesthetized spontaneously hypertensive rat. |
| Q36165784 | Increase of arginase activity in old apolipoprotein-E deficient mice under Western diet associated with changes in neurovascular unit |
| Q28390561 | Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice |
| Q23909575 | Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries |
| Q36380638 | Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice |
| Q37913979 | Kidney aging--inevitable or preventable? |
| Q37714641 | Korean red ginseng water extract restores impaired endothelial function by inhibiting arginase activity in aged mice |
| Q40976363 | Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries |
| Q35095540 | Mechanisms of improved aortic stiffness by arotinolol in spontaneously hypertensive rats |
| Q48023486 | Mechanistic studies of AVE3085 against homocysteine in endothelial protection. |
| Q60919681 | New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease |
| Q34664336 | New approaches to the design and discovery of therapies to prevent erectile dysfunction |
| Q36717720 | Nitric oxide signaling in the microcirculation |
| Q37987724 | Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases |
| Q26830146 | Nitric oxide synthases in heart failure |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q34981297 | Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging |
| Q34726830 | Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury |
| Q37773166 | Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. |
| Q64073912 | Ocimum gratissimum Linn. Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats |
| Q37375385 | Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents |
| Q35217467 | Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidants |
| Q35708220 | Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway |
| Q38133938 | Oxidative stress in aging--matters of the heart and mind. |
| Q93072001 | Perturbations of the arginine metabolome following exposures to traffic-related air pollution in a panel of commuters with and without asthma |
| Q58777359 | Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction |
| Q46675845 | Poly(ADP-ribose)polymerase 1 inhibition protects against age-dependent endothelial dysfunction |
| Q41412735 | Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging |
| Q56977995 | Potential Pitfalls in Analyzing Structural Uncoupling of Endothelial NO Synthase: Aging is Not Associated with Increased Enzyme Monomerization |
| Q90929432 | Prenatal hypoxia affected endothelium-dependent vasodilation in mesenteric arteries of aged offspring via increased oxidative stress |
| Q36787307 | Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. |
| Q48009161 | Pulmonary arterial hypertension in rats due to age-related arginase activation in intermittent hypoxia |
| Q37446110 | Redox signaling in cardiovascular health and disease. |
| Q90248915 | Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arterioles |
| Q34617217 | Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans |
| Q49993782 | Role of Thioredoxin in Age-Related Hypertension. |
| Q36837617 | Role of arginase in vessel wall remodeling |
| Q35920339 | Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms |
| Q35555933 | Role of nitric oxide in placental vascular development and function |
| Q37096869 | S-nitrosation of arginase 1 requires direct interaction with inducible nitric oxide synthase |
| Q24630263 | S-nitrosylation in cardiovascular signaling |
| Q28386564 | Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice |
| Q35080513 | Superoxide signaling in perivascular adipose tissue promotes age-related artery stiffness |
| Q36130821 | Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice |
| Q93159118 | The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia |
| Q47253015 | The Effects of Baicalin on Myoglobinuric Acute Renal Failure in Rats |
| Q48507914 | The Impact of Aging on Cardio and Cerebrovascular Diseases. |
| Q35790757 | The effects of arginase inhibitor on lung oxidative stress and inflammation caused by pneumoperitoneum in rats. |
| Q36754916 | The first description of complete invertebrate arginine metabolism pathways implies dose-dependent pathogen regulation in Apostichopus japonicus |
| Q37210044 | Transcriptomic Insights into the Response of Placenta and Decidua Basalis to the CpG Oligodeoxynucleotide Stimulation in Non-Obese Diabetic Mice and Wild-Type Controls |
| Q36848221 | Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection. |
| Q36246065 | Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis |
| Q42498817 | Upregulation of arginase-II contributes to decreased age-related myocardial contractile reserve |
| Q34022778 | Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans |
| Q36012138 | Vascular Aging in Women: is Estrogen the Fountain of Youth? |
| Q38660086 | Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. |
| Q35576389 | p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity |
Search more.